Test Price
2,800 AED✅ Home Collection Available
WDPCP Gene Bardet‑Biedl Syndrome Type 15 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل WDPCP Gene متلازمة بارديه-بيدل النوع 15 NGS الجيني في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189‑accredited NGS processing, utilising deep coverage and ACMG 2026 variant interpretation.
Premium Logistics: Paid Hospital‑Grade Home Collection 8 AM‑11 PM daily, with ISO‑certified cold‑chain transport for DNA/whole blood/FTA cards.
Clinical Guidance: Complimentary 15‑minute telephonic post‑test clinical guidance with a DHA‑licensed genetic counsellor to help interpret your result.
Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
الملخص التنفيذي
دقة تشخيصية بنسبة 99.9% من خلال تسلسل الجينوم عالي التغطية المعتمد وفق ISO 15189. خدمة سحب منزلي على مستوى المستشفيات مع نقل مبرد معتمد، وإرشاد سريري هاتفي بعد الفحص، وتحقق مباشر من التأمين عبر واتساب.
Overview – WDPCP Gene Bardet‑Biedl Syndrome Type 15 Test
This advanced Genetic Test analyses the full coding region of the WDPCP gene to confirm Bardet‑Biedl Syndrome Type 15, a rare autosomal recessive ciliopathy. يستخدم الاختبار لتأكيد التشخيص الجيني في حالات الفشل الكلوي المبكر والسمنة وفقدان البصر لدى الأطفال.
| Feature | Our Test (Premium) | Standard Alternative |
|---|---|---|
| Methodology | NGS on Illumina NovaSeq X Plus with 100 % coverage of WDPCP exons ±10 bp flanking introns, CNV detection included | Sanger sequencing only (limited to preselected variants) |
| Diagnostic Precision | >99.9% sensitivity, >99.9% specificity; ACMG 2026 variant interpretation | Variable; lower analytical sensitivity for mosaicism |
| Turnaround Time | 3–4 weeks from sample receipt; expedited reporting available | 4–6 weeks or longer |
| Home Collection | Included – hospital‑grade phlebotomy 8 AM‑11 PM | Often not available or surcharge applied |
Physician Insight & Safety Protocol
“As a DHA‑licensed clinical geneticist, I emphasize that a positive WDPCP result must be correlated with detailed renal, retinal, and endocrine phenotyping. This test is a powerful tool, but it is not a standalone diagnosis; a thorough clinical evaluation and genetic counselling are essential to guide management and family planning. I encourage you to discuss every finding with a multidisciplinary team.”
— Dr. PRABHAKAR REDDY, DHA License 61713011
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic test results do not replace ongoing therapeutic management, particularly in cases of renal impairment or hormonal disorders like diabetes insipidus or hypothyroidism that may be associated with Bardet‑Biedl syndrome.
Important Safety Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Acute febrile illness requiring urgent care; inability to provide informed consent; known coagulopathy unless a buccal swab or FTA card is used.
- ER Red Flags – seek immediate emergency care if you experience: Sudden vision loss, severe abdominal pain with vomiting (possible renal crisis), or acute onset polydipsia/polyuria in a known BBS patient.
Frequently Asked Questions
What does a positive WDPCP gene mutation confirm?
A positive result with a known pathogenic WDPCP variant confirms the clinical diagnosis of Bardet‑Biedl syndrome type 15, a multisystem ciliopathy affecting kidneys, retinas, and the neuroendocrine axis. This molecular diagnosis guides prognosis, targeted surveillance for renal failure and blindness, and informs reproductive risk for family members. Any detected variant is classified according to ACMG 2026 guidelines, and a copy of the variant interpretation report is provided.
ما أهمية الاستشارة الوراثية قبل إجراء هذا الفحص؟
جلسة الاستشارة الوراثية قبل الفحص ضرورية لرسم شجرة العائلة وتحديد نمط الوراثة المتنحية وتقييم المخاطر على الأشقاء والأبناء. تساعد في الحصول على موافقة مستنيرة وتفسير النتائج بدقة، خاصة مع احتمالية اكتشاف طفرات غير مؤكدة الأهمية السريرية. ننصح جميع المرضى بحضور جلسة استشارة مع مستشار وراثي معتمد من هيئة الصحة بدبي.
Can this test be done on a newborn or child?
Yes, the WDPCP genetic test can be performed on a newborn or child using a blood spot (FTA card) or a small whole blood sample, following explicit parental consent in compliance with UAE CDS Law 2026. Testing minors for Bardet‑Biedl syndrome should be done when clinical signs (polydactyly, renal anomalies, early‑onset obesity) are present or when a family‑specific mutation is known. A paediatric geneticist must be involved in pre‑ and post‑test counselling.
Test offered in compliance with UAE Federal Decree‑Law No. 41 of 2024 (Art. 87) on genetic privacy, UAE PDPL data protection, and CDS Law 2026 for minors.
ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). All laboratory processing follows CAP/CLIA international standards under DHA supervision.
For booking, insurance verification, or a pre‑ genetic counselling appointment, WhatsApp +971 54 548 8731.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians